Ocular Allergy

VA and visual function go the way of ocular inflammation

Tool for quantifying measures may predict outcomes for patients.

FDA approves cyclosporine A eye drop for vernal keratoconjunctivitis

Most patients with allergic disorder are children, adolescents, or young adults.

Santen earns FDA approval for cyclosporine ophthalmic emulsion eye drops to treat vernal keratoconjunctivitis

Santen Inc. announced Thursday that the U.S. FDA has approved Verkazia (cyclosporine ophthalmic emulsion) 0.1% eye drops to treat vernal keratoconjunctivitis (VKC).